PHT and Clients Convene to Discuss PRO Validation, Integrity of Electronic Records, and Optimized Trial Designs at

BOSTON, MA, Jun 19 (MARKET WIRE) --
PHT Corporation, the market-leading provider of electronic patient
reported outcome (ePRO) solutions used in more than 350 clinical trials
worldwide, welcomed industry thought leaders to its fifth annual European
User Group Meeting, which clients ranked as the best PHT ePRO meeting
they have ever attended. Clients in attendance included Lundbeck,
Novartis, Philip Morris International, Pierre Fabre, Roche, Servier and
Wyeth.

"The PHT European User Group Meeting features excellent presentations
including special case studies," noted Bruno Thedenat, Technology Project
Manager at Wyeth Pharmaceuticals. "The meeting is a unique opportunity to
have open conversations about ePRO experiences with PHT and other
pharmaceutical companies. I look forward to next year."

The two-day agenda included topics such as subject safety, PRO validation,
data analysis and trial design. Guest speakers highlighted experiences
conducting ePRO trials and the site user's perspective on eDiaries.

Conference attendees also said they enjoyed the interactive Breakout
Sessions which explored key topics in eClinical research in great detail
with subject matter experts both from PHT and from the client community.
Participants selected their topics of interest and were encouraged to
brainstorm future enhancements and requirements in these interactive and
dedicated sessions.

PHT executives in attendance included Phil Lee, President and CEO; Stephen
Raymond, PhD, Founder and Chief Scientific and Quality Officer; Linda
Beneze, Vice President of Sales and Client Services; Sheila Rocchio, VP of
Marketing; Ian McLeod, VP of Development; Jodi Holman, Director of
Customer Operations; and Dwight Cooper, Global Director, Technical
Services.

"Each year, our European User Group Meeting is a key opportunity for
clients to learn from each other and to affect our development strategy,"
said Phil Lee, PHT President and CEO. "The world's leading trial sponsors
have established PHT products and services as de facto standards in ePRO
based on significant improvements they deliver in patient safety, data
quality and trial management efficiencies. These meetings are essential
for us to maintain our strong client relationships through the open
exchange of ideas and thought-leadership."

About PHT Corporation

Trust your patient and questionnaire data again. PHT is the market-leading
provider of electronic patient reported outcome (ePRO) solutions used in
more than 350 clinical trials by 90 biopharmaceutical clients. The proven
LogPad(R) System and revolutionary SitePad(TM) Tablet deliver the voice of
the patient, in 80 languages, from homes and sites in 60 countries around
the world. By capturing high-quality and time stamped assessments with
minimal respondent burden, transmitted over reliable analog and wireless
global technologies, sponsors are able to run smaller and more conclusive
clinical research programs. Real-time study management through PHT
StudyWorks(TM) features eClinical data integration, standard and custom
data summaries for compliance and enrollment, SafetyPRO(TM) email alerts,
and the industry's premier study archive. Patient experiences captured
firsthand by PHT's ePRO Product Suite have been used successfully in at
least seven known NDA approvals to date. For more information, review
interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad and SitePad are among the registered trademarks and trademarks
of PHT Corporation.

Media contact:
Brenda Nashawaty
Email Contact
617-688-3253

Copyright 2008, Market Wire, All rights reserved.

-0-